CA-SKYLOOM
6.9.2022 09:01:47 CEST | Business Wire | Press release
Skyloom and Space Compass (a newly formed joint venture between NTT and SKY Perfect JSAT) today announced that the companies signed a term sheet aimed to launch the first geostationary-based (GEO) data relay service over Asia that will leverage Skyloom’s cutting-edge communication and networking systems for the purpose of serving the rapidly growing Earth-Observation (EO) market for real-time, high-capacity, direct-to-cloud data transfer. The companies plan to deploy the first network infrastructure node over Asia in 2024 and anticipate expanding the GEO constellation to provide additional capacity and global coverage by 2026.
Global EO providers are rapidly expanding their constellations, thus creating immense amounts of data, typically in low-earth-orbit (LEO). The Compass-Skyloom system will provide an avenue for immediate, cost-effective transfer of EO data via GEO satellite direct to cloud so that their customers and end-users can leverage perishable information on a real-time basis. The system will rely on optical/laser communications terminals, enabling fibreless optical communications at the speed of business. The partnership combines the space heritage and operations experience of SKY Perfect JSAT, the telecommunications prowess of NTT, and the cutting-edge innovation of Skyloom to unveil both a joint architecture and service for the EO market.
"This new team, leveraging the state-of-the-art telecom technology and infrastructure solutions of Skyloom, will enable us to jointly deliver best-in-class service to our earth observation customers,” said Koichiro Matsufuji, Co-CEO, Space Compass.
“Skyloom is thrilled to be joining forces with Space Compass – which draws on the strengths of two market leaders in space operations and telecommunications. Together we look forward to providing groundbreaking data transport capabilities to the earth observation market, and this is only the beginning of what’s to come,” said Marcos Franceschini, Founder & CEO, Skyloom Global.
"By this partnership, we are excited to be able to provide ultra high-speed and real time data relay in a very economical manner for our customers as a first step toward a larger non-terrestrial network. We believe optical data relay technology is a keystone to innovate networking and computing in orbit between GEO, LEO and ground,” added Shigehiro Hori, Co-CEO, Space Compass.
About Space Compass Corporation
Space Compass is a joint venture company between NTT, Japanese ICT giant, and SKY Perfect JSAT Corporation, Asia’s largest satellite operator. We will launch a Space Integrated Computing Network to aid the realization of a sustainable society. For more information, visit our corporate website, space-compass.com.
About Skyloom Global Corporation
Skyloom is an Oakland, CA-based telecommunications innovator founded with the mission to develop, deploy, and operate one of the fundamental pieces of tomorrow's space communication infrastructure for the provision of data transport services on a planetary scale. They leverage deep heritage in space optical communications to enable real time data transfer so that customers and decisionmakers can leverage perishable information. www.skyloom.co
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005414/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Steps Into Its Next Chapter11.6.2026 13:33:00 CEST | Press release
Dr. Tracy Laabs named Director; Prof. Dr. Erwin Böttinger honored for his transformative leadership The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simult
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 13:24:00 CEST | Press release
Nearly two-thirds of patients aged 80+ treated with BRUKINSA remained progression-free at six years, despite advanced age and high-risk featuresNew European patient research reveals safety, disease severity, and effectiveness are the top drivers for first-line CLL treatment decisions – not time on therapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D.,
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations11.6.2026 13:00:00 CEST | Press release
Once-daily oral zasocitinib demonstrated statistical superiority over deucravacitinib for all primary and key secondary endpoints in plaque psoriasis study More than 35% of zasocitinib-treated patients achieved complete skin clearance (PASI 100) at week 16 – more than 2.5 times the response rate for deucravacitinib Safety profile was consistent with previous studies with no new safety signals identified Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, to deucravacitinib in adults with moderate-to-severe plaque psoriasis (PsO). In the LATITUDE Atlas (TAK-279-PsO-3004) head-to-head study, zasocitinib demonstrated statistical superiority over deucravacitinib for the primary endpoint, Psoriasis Area and Severity Index (PASI) 100 response rate at week 16. The study also demonstrate
Clearlake Expands Liquid Credit Platform With Acquisition of LCM Asset Management’s CLO Contracts11.6.2026 13:00:00 CEST | Press release
Transaction adds 31 CLOs and more than $5 billion of AUM, strengthening Clearlake Credit’s position in liquid credit Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced that its credit platform, Clearlake Credit, will assume management of CLOs managed by LCM Asset Management, LLC. The transaction adds 31 CLOs representing more than $5 billion of assets under management and increases assets managed by Clearlake Credit to approximately $39 billion across liquid credit, private credit, and other customized credit solutions. The acquisition further broadens the Firm’s capabilities, deepens its relationships with institutional investors, and reinforces its client-centric approach and commitment to seeking attractive risk-adjusted returns across market cycles. Milbank LLP and Dechert LLP represented Clearlake Credit in the transaction
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries11.6.2026 12:30:00 CEST | Press release
Partnership brings together LTTS’ expertise in its Sustainability segment and the Databricks platform to accelerate Engineering Intelligence across industrial operations. L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to co-develop and deliver Industrial AI solutions that advance Engineering Intelligence (EI) for asset-intensive enterprises. Anchored in LTTS' Sustainability segment, spanning Process Engineering, Discrete Manufacturing and Industrial Products, the partnership will support Energy, Petrochemicals and Industrials clients globally. As industrial organizations seek to unlock greater value from decades of operational and engineering data, the alliance will combine LTTS’ deep domain capabilities with the Databricks platform to transform complex plant data into Engineering Intelligence - enabling improved asset reli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom